ACTIONABLE INSIGHT INTO YOUR
child’s health Readygen Box ReadyGen Box

ReadyGen is an innovative and advanced pediatric screening test that empowers parents to further protect their children by delivering timely and personalized health insights. Through our partnership, CBR families will receive two tests for the price of one:

A screening for 200+ genetic conditions that can affect children before the age of 10. Many of these conditions can't be detected by standard prenatal tests or state newborn screenings.* ReadyGen only screens for conditions that can be managed with diet, medication, or other therapies.

A pharmacogenomics panel that predicts responses to 40+ medications that may be prescribed during childhood. This report helps a child's doctor choose medications tailored to a child's unique genetic profile.

Down Arrow
ReadyGen Box Down Arrow
ReadyGen Pediatric Screening
Analyzes DNA

Early detection of 200+ conditions through advanced DNA sequencing technology**

stem cell therapies

Actionable information: all conditions can be managed with diet, medication, or other therapies (including 20+ addressable with newborn stem cells)

Requires only a cheek swab

Requires only a cheek swab—noninvasive and easy!

ReadyGen Pharmacogenomic Testing
Analyzes your child’s response or sensitivity

Analyzes your child’s response or sensitivity to 40+ medications

Helps doctors recommend

Provided to your child’s doctor to help recommend personalized medications in the future

Requires only a cheek swab

Requires only a cheek swab—noninvasive and easy!

Order your test kit today
For a limited time, receive both tests for only $579.

Pediatric Screening

Pediatric Screening

200+ genetic conditions, including 20+ conditions treatable with newborn stem cells. See sample report

  • Blood Diseases
    • Beta thalassemia
    • Congenital amegakaryocytic thrombocytopenia
    • Dyskeratosis congenita
    • Fanconi anemia
    • Sickle Cell Disease
  • Cancer
    • Wilms Tumor
  • Immune Diseases
    • Adenosine deaminase deficiency
    • Congenital neutropenia
    • Chronic granulomatous disease
    • Omenn syndrome
  • Metabolic Disorders
    • Gaucher disease
    • Hunter syndrome (MPS-II)
    • Hurler syndrome (MPS-IH)
    • Krabbe Disease
    • Mannosidosis
    • Maroteaux-Lamy Syndrome (MPS-VI)
    • Morquio Syndrome (MPS-IV)
    • Mucolipidosis II (I-cell Disease)
    • Neuronal Ceroid Lipofuscinosis (Batten Disease)
    • Niemann-Pick Syndrome
    • Sanfilippo Syndrome (MPS-III)
    • Scheie Syndrome (MPS-IS)
    • Tay Sachs Disease
    • X-Linked Adrenoleukodystrophy
Pharmacogenomic Testing

Pharmacogenomic Testing

Analyzes your child's response or sensitivity to 40+ medications, allowing your doctor to create a personalized treatment plan. See sample report

  • Analgesics
    • Celecoxib (CYP2C9)
    • Codeine (CYP2D6)
    • Hydrocodone (CYP2D6)
    • Oxycodone (CYP2D6)
    • Tramadol (CYP2D6)
  • Antibiotics
    • Aminoglycosides (MT-RNR1)
  • Anticoagulants
    • Warfarin (CYP2C9, VKORC1)
  • Anticonvulsants
    • Fosphenytoin (CYP2C9)
    • Phenytoin (CYP2C9)
  • Antiemetics
    • Ondansetron (CYP2D6)
  • Antifungal Agents
    • Voriconazole (CYP2C19)
  • Antidepressants
    • Amitriptyline (CYP2D6, CYP2C19)
    • Citalopram (CYP2C19)
    • Clomipramine (CYP2D6, CYP2C19)
    • Desipramine (CYP2D6)
    • Doxepin (CYP2D6, CYP2C19)
    • Escitalopram (CYP2C19)
    • Fluoxetine (CYP2D6)
    • Fluvoxamine (CYP2D6)
    • Imipramine (CYP2D6)
    • Nortriptyline (CYP2D6)
    • Paroxetine (CYP2D6)
    • Sertraline (CYP2C19)
    • Trimipramine (CYP2D6, CYP2C19)
  • Antilipemic Agents
    • Simvastatin (SLCO1B1)
    • Antineoplastic Agents
    • Capecitabine (DPYD)
    • Fluorouracil (DPYD)
    • Mercaptopurine (TPMT)
    • Thioguanine (TPMT)
  • Antiplatelet Agents
    • Clopidogrel (CYP2C19)
  • Antipsychotics
    • Aripiprazole (CYP2D6)
    • Iloperidone (CYP2D6)
    • Pimozide (CYP2D6)
  • Antiretrovirals
    • Atazanavir (UGT1A1)
  • Immunosuppressants
    • Azathioprine (TPMT)
    • Tacrolimus (CYP3A5)
  • Enzyme Inhibitors
    • Eliglustat (CYP2D6)
  • Psychotropics
    • Atomoxetine (CYP2D6)

Order your test kit today

Requires only a cheek swab—noninvasive and easy.

Questions

Questions? Visit FAQs or call 1-888-489-0035

*Worldwide, approximately 1 in 27 children screen positive for a genetic condition on the ReadyGen panel. If your child screens positive, a genetic counselor will contact you to discuss the results of the test and help you navigate next steps. The chance of a positive result varies depending on ethnicity.

**All of the genes have a well-established relationship with disease and meet eligibility criteria as set by ClinGen guidelines (https://clinicalgenome.org/start/ PMID: 28552198).

Evidence supporting associations between variants and drug response is obtained from a combination of sources, including: FDA drug labeling, guidelines written by a consortium of international experts (such as CPIC), and peer-reviewed research literature.